Services

Shaping the Future of Payload Delivery for Cell and Gene Therapies.

Lab

Transform Your Research

With our specialized expertise in viral vector development and optimization to ensure efficient and effective therapeutic delivery and accelerate breakthroughs in disease treatment.

Customized Viral Vector Design

We specialize in providing tailored viral vector solutions to empower your research and development initiatives for advanced therapies. With our cutting-edge technologies and extensive expertise, we deliver high-quality viral vectors designed to meet the specific needs of your therapeutic and target tissue, facilitating advancements in targeted delivery.

Microscope
Cutting edge technology
Molecule
Extensive expertise
DNA
High quality viral vectors

Viral Vector Design Services

Custom design services for novel viral vectors across the spectrum of carriers:
  • Lentivirus (LVV): third-generation IP-free vectors; integrase-deficient (IDLV) platform
  • Retrovirus (RV) including self-inactivating versions using Carrigent’s retro-SIN vector backbone
  • Adeno-associated virus (AAV)
  • Adenovirus (AdV)
  • Herpes simplex virus (HSV)
Contract services that support viral vector design:
  • Plasmid optimization
  • Viral-related assay services
  • Viral labelling
  • Stable Producer line generation

Advance Your Research

Through innovative custom cell line development solutions.

Lab
DNA
Gene-edited cell lines
Hopper
Higher titers
DNA
Larger GOI inserts

Custom Cell Line Development

Carrigent is dedicated to advancing research through innovative custom cell line development solutions that result in higher titers and larger packaging inserts. Our expertise in viral vector and gene-editing technologies enables us to create tailored cell lines that meet the unique demands of your vector.

By integrating advanced methodologies with our state-of-the-art technologies, we empower researchers to explore new frontiers in protein function, drug discovery, and cellular behavior analysis.

Cell Line Development Services

Viral vector and gene-edited cell line development services:
  • Custom design
  • Clone isolation
  • Identification
Innovative, patent-pending cell line modification technology that produces viral vectors with:
  • Higher titers
  • Increased viral genome loading capacity
  • Enhanced viral genome stability
Advanced technology integration services:
  • Custom gene-editing service: Enhancing protein function research and facilitating lead compound identification for drug discovery
  • Viral vector-mediated cell painting technology: supporting live cell monitoring and analyzing changes in cell behavior
  • Targeted cell line development: custom design and modification monitoring systems for specific research applications
Lab

Ready to Move Beyond

Viral Vector Design?

We offer custom process development services and preclinical viral vector production for researchers in need of knowledgeable yet flexible partners.

Preclinical Viral Vector Production

Preclinical Viral Vector Process Development and Production

Carrigent offers custom process development services as well as preclinical production of virus at a range of scales. We currently can produce virus at up to a 200L scale.

Rather than fitting your process to a fixed, inefficient production platform, Carrigent maintains a diversity of production technologies to identify the process that is most effective for your application.

Virus Scale Chart

Viral Vector Design Services

Custom design services for novel viral vectors across the spectrum of carriers:
  • Lentivirus (LVV): third-generation IP-free vectors; integrase-deficient (IDLV) platform
  • Retrovirus (RV) including self-inactivating versions using Carrigent’s retro-SIN vector backbone
  • Adeno-associated virus (AAV)
  • Adenovirus (AdV)
  • Herpes simplex virus (HSV)
Contract services that support viral vector design:
  • Plasmid optimization
  • Viral-related assay services
  • Viral labelling
  • Stable Producer line generation

License Our Technology

We offer a unique technology licensing approach.

Lab
Money
Affordable fee for service approach for design services
Calendar
Milestone-based options at clinical phase
Rocket
Royalty-based payments at launch

Technology Licensing

Carrigent offers both exclusive and non-exclusive licensing of our technologies with an approach that de-risks your investment at early stages of development. Custom-designed vector and cell line technologies are provided royalty-free for the entirety of your product's lifecycle.

Our internally-developed technologies are free to access through early-stage clinical development to maximize your ability to complete your development objectives, with milestone-based payments and royalties not applied until late clinical and commercial stages of your therapeutic.

Interested in Innovative Cell Line Modification?

Reach Out
Carrigent